Wordt geladen...
Novel Treatments for Systemic Lupus Erythematosus
There are many new therapeutic directions for the disease systemic lupus erythematosus (SLE). Despite this, the US Food and Drug Administration (FDA) has approved only one biological agent and it involves B cells, now thought to play a significant role in the pathogenesis of SLE. The name of the dru...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3383530/ https://ncbi.nlm.nih.gov/pubmed/22870484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X11415456 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|